White House Stands By Behind-The-Scenes Deal With Drugmakers Under Industry Pressure
New York Times:
Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion.
Read the whole story: New York Times



First Posted: 09/06/09 06:12 AM ET Updated: 05/25/11 02:45 PM ET